Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Global $3.75 Billion Genetic Sequencing Test Market Analysis, Opportunities and Forecasts 2014-2018 & 2019-2024


DUBLIN, Dec. 9, 2019 /PRNewswire/ -- The "Global Genetic Sequencing Test Market: World Market Analysis By Technology Type, By Test Type, By Products, By End User, By Country: Opportunities and Forecast (2019-2024)" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Genetic Sequencing Test Market was valued at USD 3750 Million in the year 2018

Increase in number of old age population, increase in number of diseases, decrease in the cost of sequencing, increasing need for better healthcare are the basic reasons behind increased demand for the global sequencing market. Global Genetic Sequencing Test Market will continue to grow as the leading companies launch new sequencing products with increased efficiency and less time consumption.

Therefore, usage by healthcare set ups, research institutes, biotechnology centres is increasing. These markets are influenced by the cost factor for the end users. Also developing countries, which suffer from lack of funding, are not able to use this technology to the fullest.

On the basis of Technology, the segments are First Generation Sequencing and Next Generation Sequencing. The older technology is costly as well as time consuming but it is still considered as Gold Standard to validate the result obtained by next generation sequencing. Next Generation Technology provides long reads which have drastically reduced the cost and result annotation time.

Among the country, United States of America currently leads the genetic sequencing market owing to considerable investments being done in healthcare sector. Also, presence of leading market players like Illlumina in this region makes the technology more readily available. Moreover, countries like China, India, Germany, Netherlands, Saudi Arabia are expected to grow faster owing to increased investment in the research and development.

Scope of the Report

Global Genetic Sequencing Test Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

Country Analysis - U.S., India, China, France, Rest of the World (Actual Period: 2014-2018, Forecast Period: 2019-2024)

Other Report Highlights

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/6hdt3a

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 17:45
The "Cold Chain Monitoring - Global Strategic Business Report" has been added to  ResearchAndMarkets.com's offering. The global market for Cold Chain Monitoring estimated at US$7.3 Billion in the year 2023, is projected to reach a revised size of...

at 17:31
Sparkling Logic today announced the launch of AI Assistant, an interactive tool that enables users to complete decision management tasks through generative AI.An add-on to the SMARTStm decision management platform, AI Assistant provides guided,...

at 17:30
The "Business Travel - Global Strategic Business Report" has been added to  ResearchAndMarkets.com's offering. The global market for Business Travel estimated at US$690.6 Billion in the year 2023, is projected to reach a revised size of US$928.4...

at 17:28
The Federal Mediation and Conciliation Service (FMCS) is proud to announce the launch of its newest educational initiative: the "FMCS 101" video series. Designed to provide a comprehensive overview of the Agency's mission, services, and history, the...

at 17:26
NaaS Technology, the first U.S. listed EV charging service company in China, announced remarkable financial growth and operational highlights in its newly-released unaudited financial results for the fourth quarter and full year ended December 31,...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...



News published on and distributed by: